TEVA PHARMACEUTICALS

India recently decided to open up its equity market to individual foreign investors. The hope is that allowing foreign investors to buy Indian stocks directly would help reverse a year-long decline in Indian stock prices and lead to more foreign investment in the Indian economy. If you're not ready...

Here's a quick look at some of the top performing health care stocks, year to date. These stocks all have a market cap of more than $1 billion and all pay a dividend. Baxter International (NYSE: BAX) is more than 11% higher than a month ago, and more than 17% higher than a year ago. The company...

Lazard Capital Markets has upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Hold to Buy and has established a $33 price target following the settlement of patent litigation with Teva Pharmaceuticals (NASDAQ: TEVA).

Needham has raised the price target on Cubist Pharmaceuticals (NASDAQ: CBST) from $27 to $33 and following the company's settlement with Teva (NASDAQ: TEVA). Buy rating maintained.

According to Deutsche Bank, Procter & Gamble (NYSE: PG) announced this morning it is forming a JV with Teva Pharmaceuticals comprised of both companies' existing OTC businesses outside of North America. Deutsche Bank reported that P&G will own 51% with Teva owing 49% and P&G will...

Teva Pharmaceutical Industries (NASDAQ: TEVA) said on Thursday it would acquire Germany's Ratiopharm for $4.95 billion, including debt. It's unusual for an acquirer’s stock to go up after announcing a takeover but Teva has a history of smart takeovers. Teva's stock is presently up 3%. Here are...